Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

This example shows a report table, trial design, and results data for the in vitro Neutral Red Uptake Cytotoxicity Assay neutral red uptake (NRU) cytotoxicity assay in example study 123.

Expand
titleStudy 123, Sample from Report Table

The following shows the data as it is represented example data for study 123 in a report table for study 123.   This report includes summary statistics (i.e.g. Average, Standard Deviation, Coeff. Var., average, standard deviation, coefficient variation) for each plate and an EC50 value for the entire assay. The grey cells in In the table below, the light grey shading for plate 1 are cells values from wells that do not contain the CHO Hamster cells. NHK cells. The dark grey shading represents the column and row location within the 96-well plate, and in this example the applicant chose to use these column and row locations to assign their REFID values in the RELREF dataset and GT dataset.  

For brevity, the datasets in this example are not comprehensive but are intended to demonstrate a range of proper use. 


Neutral

Neutral

Red Cytotoxicity Assay Results (Relative Absorbance Data)




Sample ID

Smoke Regime

Replicate Number

Plate Number

Well Number



Relative Assay Plate Absorbance Readings





Cigarette Smoke Condensate (µg/mL) 

SLS (µg/mL)


EC50 (µg/ml)

0

Well Column:

1

2

3

4

5

6

7

8

9

10

11

12


Well 
Row:

0

10

50

75

100

120

140

160

200

110

200

0



030001

Medium

1

1

1

A

0.046*

0.046*0.039*0.012*0.030*0.003*0.057*0.032*0.003*0.050*0.044*

0.040*



030001

Medium

1

1

2

B

0.048*

107

77.7

65.7

30.2

15.6

9.79

5.41

2.49

8.09

0.791

0.014*



030001

Medium

1

1

3

C

0.005*

98.6

77.4

57.7

35.8

8.09

7.36

3.22

0.791

6.38

0.061

0.050*



030001

Medium

1

1

4

D

0.049*

94.9

81.5

38.2

31.2

7.60

5.17

3.22

0.791

5.17

0.304

0.017*



030001

Medium

1

1

5

E

0.047*

111

78.1

64.5

32.9

8.82

5.90

2.74

1.28

10.3

0.547

0.011*



030001

Medium

1

1

6

F

0.032*

96.6

76.2

48.0

26.8

7.84

4.20

2.74

1.52

8.09

4.93

0.022*



030001

Medium

1

1

7

G

0.044*

105

77.9

58.2

28.3

8.09

4.68

1.76

0.547

8.57

1.76

0.056*



030001

Medium

1

1

8

H

0.056*

0.013*0.040*0.008*0.013*0.002*0.029*0.018*0.006*0.016*0.024*

0.046*


Average


101

78.2

54.5

29.9

9.70

6.17

3.37

1.19

8.94

1.22



Std. Dev.


6

2.9

9.4

3.6

2.95

2.19

1.12

0.72

2.72

1.58



Coeff. Var.


5.8

3.6

17.2

11.9

30.4

35.5

33.1

61.0

30.5

129.9



*media without cells















030001

Medium

1

2

1

A


93.4

74.0

56.0

35.1

11.8

8.70

5.10

1.98

5.34

1.02




030001

Medium

1

2

2

B


102

75.2

53.3

35.1

11.8

7.74

5.58

3.66

5.34

1.02




030001

Medium

1

2

3

C


107

79.0

55.0

26.5

10.1

6.06

3.66

1.74

7.02

0.780




030001

Medium

1

2

4

D


104

80.2

55.3

29.8

8.94

3.90

3.66

1.50

6.30

0.780




030001

Medium

1

2

5

E


101

75.7

54.1

26.7

4.86

4.38

1.26

1.02

6.30

1.02




030001

Medium

1

2

6

F


110

85.7

67.7

26.0

5.34

4.62

3.42

1.50

6.30

0.540




030001

Medium

1

2

7

G


104

77.8

64.9

27.7

8.22

3.18

2.46

1.02

6.30

0.780




030001

Medium

1

2

8

H


103

71.6

58.9

25.5

9.42

4.14

3.90

1.26

4.38

0.780



Average


103

77.4

58.1

29.0

8.82

5.34

3.63

1.71

5.91

0.840



Std. Dev.


5

4.4

5.3

4.0

2.63

1.97

1.37

0.86

0.83

0.170



Coeff. Var.


4.6

5.6

9.2

13.6

29.8

36.9

37.6

50.0

14.1

20.2



EC50 (µg/ml). Effective concentration at 50% cytotoxicity.  (using a specific sigmoidal equation = model).

(could also be EC20 or EC30, EC70, etc.)

123

  • Assumption: A Trial (study) can have more than one assay type. (this line will be moved to the ts.xpt assumptions page)

 













123

datasetdataset-wrap
Rowcaps
two Types 8 the sponsor's study reference ID is not applicable 912 that TSGRPID Study Director Test Facility 1824 this example study includes two different species of bacteria and a total of five strains. Show that 2 for one species (Salmonella) with four different strains that are tested in this example study.Show that TSGRPID (TSGRPID = 3) has been used to link the information for one species (Escherichia coli) with the strain that is tested in this example
Rows 1-2:Show
2 records for TSPARMCD = "GLPTYP", using TSSEQ to indicate multiple records, since both GLP
types apply for this example study. 
Row
3:Shows that
this study was conducted as a GLP study.
Rows
4-
5:Show
the study start date and study title.
Rows 6-7:Show the version of SEND Implementation Guide and version of Controlled Terminology used in this study.
Row 8:Shows the applicant's organization.
Row 9:

Shows that the applicant's study reference ID is not applicable.

Rows 10-13:Show that TSGRPID has been used to link records (name, location, country) related to the test facility (TSGRPID = 1). The
study director is associated with the
test facility.
Rows
14-
16:

Show that

Rows 18-22:

TSGRPID (TSGRPID=

4) has been used to link the information

on the testing guideline followed on this study (TSTGDNAM, TSTGDORG, TSTGDVER).

Row 17:

Shows the study type for this study.

Row 18:

Shows that this study includes a Neutral Red Uptake Assay.
Rows 19-20:Show that the species is human and the cell line is NHK in this
Rows 23-24:
study.
Dataset2
Row

STUDYID

ASSAYID

DOMAIN

TSSEQ

TSGRPID

TSPARMCD

TSPARM

TSVAL

TSVALNF

1123
NRU
TS1
GLPTYPGood Laboratory Practice TypeFDA
2123
NRU
TS2
GLPTYPGood Laboratory Practice TypeOECD
3123
NRU
TS1
STSTDTCStudy Start Date2022

GLPFLGLP FlagY
4123TS1
STSTDTCStudy Start Date2022-05-25
4

5123
NRU
TS1
STITLEStudy Title

Determination of the in vitro genotoxicity potential using the in vitro Neutral Red Uptake assay

5

6123
NRU
TS1
SNDIGVERSEND Implementation Guide VersionTOBACCO IMPLEMENTATION GUIDE VERSION 1.0
6

7123
NRU
TS1
SNDCTVERSEND Controlled Terminology VersionSEND Terminology 2021-09-30
7

8123
NRU
TS1
SSPONSOR

APPLCNT
Sponsor Organization
ApplicantExample
Sponsor
Applicant Inc.
8

9123
NRU
TS1
SPREFID

APREFID
Sponsor
Applicant Study Reference ID
NOT APPLICABLE
9
10123
NRU
TS11TSTFNAMTest Facility NameExample Test Lab Name
10

11123
NRU
TS11TSTFLOCTest Facility Location10 Somewhere Street, Montgomery, AL 10000
11

12123
NRU
TS11TFCNTRYTest Facility CountryUSA
12

13123
NRU
TS11STDIRStudy DirectorDr. R. Smith
13

14123
NRU
TS1
GLPFL
4
GLP FlagY
TSTGDNAMTesting Guideline NamePublication No. 07-4519
15
14
123
NRU
TS1
ASTDAssay StandardNIH Publication No. 07-4519
4TSTGDORGTesting Guideline OrganizationNIH
16
15
123
NRU
TS1
ASTDV
4TSTGDVERTesting Guideline
Assay Standard
Version2006-11
16

17123
NRU
TS1
SSTYPStudy TypeGENOTOXICITY IN VITRO
17

18123
NRU
TS1
SSSTYPStudy Sub TypeIn Vitro Neutral Red Uptake

GNTXAIDGenetic Toxicology Assay IdentifierNRU
19123
18123NRU
TS1
SPECIESSpecies
Hamster
HUMAN
19

20123
NRU
TS1
TESTSYS

CELLLN
Test System
Cell Line
CHO
NHK
Dataset wrap
Shows the value for STRAIN/SUBSTRAIN is NO STRAIN
Rowcaps
Rows 1
-20
-12:Show the test conditions for the set with a short name or SETCD value of NRU. The applicant chose this value to represent test conditions for the entire assay. 
Rows 13-31:Show the test conditions for the set with a short name or SETCD value of CSC-50b.
 
The
sponsor
applicant chose this value to represent plate number 1, well
number 1
row A, well column 3, with a concentration of 50µg/mLof
Cigarette Smoke Condensate
cigarette smoke condensate as shown in the report table for study 123.
Row 17:
  The value for Cell Line (CELLLN) is not applicable because the well is a media-only well, having no
CHO Hamster
NHK cells.
 

Rows

21

32-

40

50:

Show the test conditions for the set with a short name or SETCD value of CSC-50.
 
The
sponsor
applicant chose this value to represent plate number 1, well rows B-G, well column 3 and plate number 2
, with a
, well rows A-H, well column 3. These all have the concentration of 50µg/mLof
Cigarette Smoke Condensate
cigarette smoke condensate as shown in the report table for study 123.
Rows
41
51-
60
69:Show the test conditions for the set with a short name or SETCD value of
CSC
SLS-
50
110.
 
The
sponsor
applicant chose this value to represent
both wells numbered 7 in
plate number 1
and 2, with a
, well rows B-G, well column 10, and plate number 2, well rows A-H, well column 10. These all have the concentration of 110µg/mLof
Sodium Laurel Sulfate
sodium laurel sulfate as shown in the report table for study 123.
Dataset2
Row
ROWSTUDYID
ASSAYID
DOMAINSETCDSETTXSEQTXPARMCDTXPARMTXVAL
1123
NRU
TX
CSC-50b
NRUNRU_ASSAY
CSC-50-blank
1
TRTDMIN
IVTDMINIn vitro Treatment Duration Minimum47.5
2123
NRU
TX
CSC-50b
NRUNRU_ASSAY
CSC-50-blank
2
TRTDTRG
IVTDTRGIn vitro Treatment Duration Target48
3123
NRU
TX
CSC-50b
NRUNRU_ASSAY
CSC-50-blank
3
TRTDMAX
IVTDMAXIn vitro Treatment Duration Maximum48.5
4123
NRU
TX
CSC-50b
NRUNRU_ASSAY
CSC-50-blank
4
TRTDU
IVTDUIn vitro Treatment Duration UnitHOURS
5123
NRU
TX
CSC-50b
NRUNRU_ASSAY
CSC-50-blank
5INCBTMPIncubation Temperature37
6123
NRU
TX
CSC-50b
NRUNRU_ASSAY
CSC-50-blank
6INCBTMPUIncubation Temperature UnitC
7123TXNRU
TXCSC-50bCSC-50-blank7WAVELGTHSpectrophotometer  WAVELENGTH IN NANOMETERS
NRU_ASSAY7SWAVENMSpectrophotometer Wavelength540
8123
NRU
TX
CSC-50b
NRUNRU_ASSAY
CSC-50-blank
8
HUMID
ATMRHPAtmospheric Relative
Humidity 
Humidity Percent90
9123
NRU
TX
CSC-50b
NRUNRU_ASSAY
CSC-50-blank
9
ATMCO2
ATMCO2PAtmospheric CO2 Percent5
10123
NRU
TX
CSC-50b
NRUNRU_ASSAY
CSC-50-blank
10
SPTOBID
SPDEVID
Sponsor
applicant defined
tobacco
device identifier
CIG01a
PUFFMASTER3k
11123
NRU
TX
CSC-50b
NRUNRU_ASSAY
CSC-50-blank
11
EXPTYP
SMKRGM

Exposure Type

Smoking RegimenMEDIUM INTENSITY REGIMEN
Air Liquid Interface
12123TXNRUNRU_ASSAY12SPTOBID

Applicant-defined tobacco identifier

CIG01a
13123TXCSC-50bCSC-50-blank
12
13
SAMTYPSample TypeWhole Smoke Conditioned Media
IVTDMINIn vitro Treatment Duration Minimum47.5
14
13
123
NRU
TXCSC-50bCSC-50-blank
13
14
INTRVNName of the Intervention ArticleTobacco ProdA
IVTDTRGIn vitro Treatment Duration Target48
15
14
123
NRU
TXCSC-50bCSC-50-blank
14
15
ITVTYPEtype of intervention articlePRODUCT
IVTDMAXIn vitro Treatment Duration Maximum48.5
16123
15123NRU
TXCSC-50bCSC-50-blank
15
16
ITVCONCintervention concentration50
IVTDUIn vitro Treatment Duration UnitHOURS
17123
16123NRU
TXCSC-50bCSC-50-blank
16
17
ITVCONCU
INCBTMP
intervention unitug/ml
Incubation Temperature37
18
17
123
NRU
TXCSC-50bCSC-50-blank
17
18
STRAINStrain/SubstrainNO STRAIN
INCBTMPUIncubation Temperature UnitC
19
18
123
NRU
TXCSC-50bCSC-50-blank
18
19
SPDEVIDSponsor defined device identifierPUFFMASTER3k
SWAVENMSpectrophotometer Wavelength540
20123
19123NRU
TXCSC-50bCSC-50-blank
19
20
DUREFIDSmoking RegimeMedium Intensity Regimen
ATMRHPAtmospheric Relative Humidity Percent90
21
20
123
NRU
TXCSC-50bCSC-50-blank
20
21
SPTOBID

Sponsor defined tobacco identifier

CIG01a
ATMCO2PAtmospheric CO2 Percent5
22123
21123NRU
TXCSC-
50
50bCSC-50-blank
1
22
TRTDMINTreatment Duration Minimum47.5
SPDEVIDapplicant defined device identifierPUFFMASTER3k
23
22
123
NRU
TXCSC-
50
50bCSC-50-blank
2
23
TRTDTRGTreatment Duration Target48
SMKRGMSmoking RegimenMEDIUM INTENSITY REGIMEN
24
23
123
NRU
TXCSC-
50
50bCSC-50-blank
3
24
TRTDMAXTreatment Duration Maximum48.5
SPTOBID

Applicant-defined tobacco identifier

CIG01a
25
24
123
NRU
TXCSC-
50
50bCSC-50-blank
4
25
TRTDUTreatment Duration UnitHOURS25123
EXPTYP

Exposure Type

Air Liquid Interface
26123
NRU
TXCSC-
50
50bCSC-50-blank
5
26
INCBTMP
SAMTYP
Incubation Temperature3726123
Sample TypeWhole Smoke Conditioned Media
27123
NRU
TXCSC-
50
50bCSC-50-blank
6
27
INCBTMPUIncubation Temperature UnitC
ITVNAMName of the Intervention ArticleTobacco ProdA
28
27
123
NRU
TXCSC-
50
50bCSC-50-blank
7
28
WAVELGTHSpectrophotometer  WAVELENGTH IN NANOMETERS540
ITVTYPEIntervention Article TypePRODUCT
29
28
123
NRU
TXCSC-
50
50bCSC-50-blank
8
29
HUMIDAtmospheric Relative Humidity  Percent90
ITVCONC

Intervention Article Concentration

50
30123
29123NRU
TXCSC-
50
50bCSC-50-blank
9
30
ATMCO2Atmospheric CO2 Percent5
ITVCONCUIntervention Article Concentration Unitug/ml
31
30
123
NRU
TXCSC-
50
50bCSC-50-blank
10
31
SPTOBID

Sponsor defined tobacco identifier

CIG01a
CELLLNCell LineNOT APPLICABLE
32
31
123
NRU
TXCSC-50CSC-50
11
32
EXPTYP

Exposure Type

Air Liquid Interface
IVTDMINIn vitro Treatment Duration Minimum47.5
33
32
123
NRU
TXCSC-50CSC-50
12
33
SAMTYPSample TypeWhole Smoke Conditioned Media
IVTDTRGIn vitro Treatment Duration Target48
34123
33123NRU
TXCSC-50CSC-50
13
34
INTRVNName of the Intervention ArticleTobacco ProdA
IVTDMAXIn vitro Treatment Duration Maximum48.5
35
34
123
NRU
TXCSC-50CSC-50
14
35
ITVTYPEtype of intervention articlePRODUCT 
IVTDUIn vitro Treatment Duration UnitHOURS
36
35
123
NRU
TXCSC-50CSC-50
15
36
ITVCONC
INCBTMP
intervention concentration
Incubation Temperature
50
37
36
37123
NRU
TXCSC-50CSC-50
16
37
ITVCONCUintervention unitug/ml37123
INCBTMPUIncubation Temperature UnitC
38123
NRU
TXCSC-50CSC-50
17
38
STRAINStrain/SubstrainCHO38123
SWAVENMSpectrophotometer Wavelength540
39123
NRU
TXCSC-50CSC-50
18
39
SPDEVIDSponsor defined device identifierPUFFMASTER3k
ATMRHPAtmospheric Relative Humidity Percent90
40
39
123
NRU
TXCSC-50CSC-50
19
40
DUREFIDSmoking RegimeMedium Intensity Regimen
ATMCO2PAtmospheric CO2 Percent5
41
40
123
NRU
TXCSC-50CSC-50
20
41
SPTOBID
SPDEVID
Sponsor
applicant defined
tobacco
device identifier
CIG01a
PUFFMASTER3k
41
42123
NRU
TX
SLS
CSC-
110
50
SLS
CSC-
110
50
1
42
TRTDMINTreatment Duration Minimum47.5
SMKRGMSmoking RegimenMEDIUM INTENSITY REGIMEN
43
42
123
NRU
TX
SLS
CSC-
110
50
SLS
CSC-
110
50
2
43
TRTDTRGTreatment Duration Target48
SPTOBID

Applicant-defined tobacco identifier

CIG01a
44
43
123
NRU
TX
SLS
CSC-
110
50
SLS
CSC-
110
50
3
44
TRTDMAXTreatment Duration Maximum48.5
EXPTYP

Exposure Type

Air Liquid Interface
45
44
123
NRU
TX
SLS
CSC-
110
50
SLS
CSC-
110
50
4
45
TRTDUTreatment Duration UnitHOURS
SAMTYPSample TypeWhole Smoke Conditioned Media
46
45
123
NRU
TX
SLS
CSC-
110
50
SLS
CSC-
110
50
5
46
INCBTMPIncubation Temperature3746123
ITVNAMIntervention Article NameTobacco ProdA
47123
NRU
TX
SLS
CSC-
110
50
SLS
CSC-
110
50
6
47
INCBTMPUIncubation Temperature UnitC
ITVTYPEIntervention Article TypePRODUCT
48
47
123
NRU
TX
SLS
CSC-
110
50
SLS
CSC-
110
50
7
48
WAVELGTHSpectrophotometer wavelength in nanometers540
ITVCONC

Intervention Article Concentration

50
49
48
123
NRU
TX
SLS
CSC-
110
50
SLS
CSC-
110
50
8
49
HUMIDAtmospheric Relative Humidity  Percent90
ITVCONCUIntervention Article Concentration Unitug/ml
50
49
123
NRU
TX
SLS
CSC-
110
50
SLS
CSC-
110
50
9
50
ATMCO2Atmospheric CO2 Percent5
CELLLNCell LineNHK
51
50
123
NRU
TXSLS-110SLS-110
10
51
SPTOBID

Sponsor defined tobacco identifier

CIG01a
IVTDMINIn vitro Treatment Duration Minimum47.5
52
51
123
NRU
TXSLS-110SLS-110
11
52
EXPTYP

Exposure Type

Air Liquid Interface
IVTDTRGIn vitro Treatment Duration Target48
53123
52123NRU
TXSLS-110SLS-110
12
53
SAMTYPSample TypeLiquid
IVTDMAXIn vitro Treatment Duration Maximum48.5
54
53
123
NRU
TXSLS-110SLS-110
13
54
INTRVNName of the Intervention ArticleSodium Laurel Sulfate
IVTDUIn vitro Treatment Duration UnitHOURS
55
54
123
NRU
TXSLS-110SLS-110
14
55
ITVTYPEtype of intervention articlePOSITIVE CONTROL
INCBTMPIncubation Temperature37
56
55
123
NRU
TXSLS-110SLS-110
15
56
ITVCONCintervention concentration200
INCBTMPUIncubation Temperature UnitC
57123
56123NRU
TXSLS-110SLS-110
16
57
ITVCONCU
SWAVENM
intervention unitug/ml
Spectrophotometer Wavelength540
58
57
123
TXSLS-110SLS-11058ATMRHPAtmospheric Relative Humidity Percent90
59123
NRU
TXSLS-110SLS-110
17
59
STRAINStrain/SubstrainCHO
ATMCO2PAtmospheric CO2 Percent5
60
58
123
NRU
TXSLS-110SLS-110
18
60SPDEVID
Sponsor
applicant defined device identifierPUFFMASTER3k
59
61123
NRU
TXSLS-110SLS-110
19
61
DUREFID
SMKRGMSmoking
RegimeMedium Intensity Regimen
RegimenMEDIUM INTENSITY REGIMEN
62
60
123
NRU
TXSLS-110SLS-110
20
62SPTOBID
Sponsor

Applicant-defined tobacco identifier

CIG01a